NewYork: The drugs behind the new pills to treat Covid-19 remain very effective against the Omicron variant of the virus in lab tests, according to a new study. However, lab tests also showed that the available antibody therapies — typically given intravenously in hospitals — are substantially less effective against Omicron than against earlier variants […]
Bamlanivimab and etesevimab combination has been authorised under Emergency Use Authorisation in the US and select EU countries for the treatment of the disease.